{ "company_number": "08415038", "name": "HOX Therapeutics Limited", "url": "/company/08415038", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2013-02-22", "dissolved_on": null, "sic_codes": [ { "code": "86900", "description": "Other human health activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86900" } ], "registered_address": { "id": 184664, "url": "/address/184664", "line1": "30 UPPER HIGH STREET", "line2": "", "post_town": "THAME", "county": "OXFORDSHIRE", "country": "ENGLAND", "postcode": "OX9 3EZ" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08415038", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-11-30", "last_made_up": "2026-02-28", "category": "SMALL", "filings": [ { "url": "/company/08415038/accounts/2026-02-28", "made_up_date": "2026-02-28", "period_start": "2025-03-01", "period_end": "2026-02-28", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": "0.06", "tangible_fixed_assets": "1032.00", "debtors": "212367.00", "cash_bank_in_hand": "1429606.00", "current_assets": "1641973.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1593750.00", "total_assets_less_current_liabilities": "1594782.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "3387.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-809905.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2026.zip" }, { "url": "/company/08415038/accounts/2025-02-28", "made_up_date": "2025-02-28", "period_start": "2024-03-01", "period_end": "2025-02-28", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": "5.00", "tangible_fixed_assets": "2218.00", "debtors": "301119.00", "cash_bank_in_hand": "785782.00", "current_assets": "1086901.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "928620.00", "total_assets_less_current_liabilities": "930838.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1969.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-1081975.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2025.zip" }, { "url": "/company/08415038/accounts/2024-02-29", "made_up_date": "2024-02-29", "period_start": "2023-03-01", "period_end": "2024-02-29", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "9905.00", "debtors": "256287.00", "cash_bank_in_hand": "852486.00", "current_assets": "2108773.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1695802.00", "total_assets_less_current_liabilities": "1705707.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1935.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-729715.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2024.zip" }, { "url": "/company/08415038/accounts/2023-02-28", "made_up_date": "2023-02-28", "period_start": "2022-03-01", "period_end": "2023-02-28", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "807.00", "debtors": "52386.00", "cash_bank_in_hand": "2495935.00", "current_assets": "2548321.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2423227.00", "total_assets_less_current_liabilities": "2424034.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1935.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-173824.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2023.zip" }, { "url": "/company/08415038/accounts/2022-02-28", "made_up_date": "2022-02-28", "period_start": "2021-03-01", "period_end": "2022-02-28", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "1269.00", "debtors": "61912.00", "cash_bank_in_hand": "130954.00", "current_assets": "192866.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "94589.00", "total_assets_less_current_liabilities": "95858.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1555.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-440534.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2022.zip" }, { "url": "/company/08415038/accounts/2021-02-28", "made_up_date": "2021-02-28", "period_start": "2020-03-01", "period_end": "2021-02-28", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "1136.00", "debtors": "120532.00", "cash_bank_in_hand": "234069.00", "current_assets": "354601.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "327209.00", "total_assets_less_current_liabilities": "328345.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1555.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "-474670.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2021.zip" }, { "url": "/company/08415038/accounts/2020-02-29", "made_up_date": "2020-02-29", "period_start": "2020-02-29", "period_end": "2020-02-29", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "3890.00", "debtors": "334541.00", "cash_bank_in_hand": "483882.00", "current_assets": "818423.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "782160.00", "total_assets_less_current_liabilities": "786050.00", "net_assets_liabilities": "786050.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1555.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2020.zip" }, { "url": "/company/08415038/accounts/2019-02-28", "made_up_date": "2019-02-28", "period_start": "2019-02-28", "period_end": "2019-02-28", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "49745.00", "debtors": "389054.00", "cash_bank_in_hand": "1088318.00", "current_assets": "1477372.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1278024.00", "total_assets_less_current_liabilities": "1327769.00", "net_assets_liabilities": "1188069.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1555.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2019.zip" }, { "url": "/company/08415038/accounts/2018-02-28", "made_up_date": "2018-02-28", "period_start": "2018-02-28", "period_end": "2018-02-28", "entity_name": "Hox Therapeutics Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "74617.00", "debtors": "101565.00", "cash_bank_in_hand": "1232284.00", "current_assets": "1333849.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1322722.00", "total_assets_less_current_liabilities": "1397339.00", "net_assets_liabilities": "1257639.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1296.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2018.zip" }, { "url": "/company/08415038/accounts/2017-02-28", "made_up_date": "2017-02-28", "period_start": "2017-02-28", "period_end": "2017-02-28", "entity_name": "Hox Therapeutics Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": null, "debtors": "7074.00", "cash_bank_in_hand": "163832.00", "current_assets": "170906.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "140051.00", "total_assets_less_current_liabilities": "140051.00", "net_assets_liabilities": "351.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1036.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2017.zip" }, { "url": "/company/08415038/accounts/2016-02-28", "made_up_date": "2016-02-28", "period_start": "2016-02-28", "period_end": "2016-02-28", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "890.00", "cash_bank_in_hand": "187972.00", "current_assets": "188862.00", "creditors_due_within_one_year": "6881.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "181981.00", "total_assets_less_current_liabilities": "181981.00", "net_assets_liabilities": "181981.00", "called_up_share_capital": "1029.00", "profit_loss_account_reserve": "-175870.00", "shareholder_funds": "181981.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2016.zip" }, { "url": "/company/08415038/accounts/2015-02-28", "made_up_date": "2015-02-28", "period_start": "2015-02-28", "period_end": "2015-02-28", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "150.00", "cash_bank_in_hand": "3892.00", "current_assets": "4042.00", "creditors_due_within_one_year": "74726.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-70684.00", "total_assets_less_current_liabilities": "-70684.00", "net_assets_liabilities": "-70684.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "-70685.00", "shareholder_funds": "-70684.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2015.zip" }, { "url": "/company/08415038/accounts/2014-02-28", "made_up_date": "2014-02-28", "period_start": "2014-02-28", "period_end": "2014-02-28", "entity_name": "HOX Therapeutics Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "21782.00", "cash_bank_in_hand": "20001.00", "current_assets": "41783.00", "creditors_due_within_one_year": "62100.00", "creditors_due_after_one_year": "0.00", "net_current_assets_liabilities": "-20317.00", "total_assets_less_current_liabilities": "-20317.00", "net_assets_liabilities": "-20317.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "-20318.00", "shareholder_funds": "-20317.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2014.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08415038/filing-history" }, "confirmation_statement": { "next_due": "2027-05-17", "last_made_up": "2026-05-03" }, "officers": [], "psc": [], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-02T05:12:20.351914+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }